Focus

Gilead

PUBLIC HEALTH INFORMATION
PUBLIC HEALTH INFORMATION

US Regulators Clear Remdesivir for COVID-19 Outpatient Use

US Regulators Clear Remdesivir for COVID-19 Outpatient Use
|
US News
US News

FDA Approves First Treatment for COVID-19, Remdesivir

FDA Approves First Treatment for COVID-19, Remdesivir
|
Europe
Europe

EU Buys Remdesivir to Treat 30,000 COVID Patients, Seeks More

EU Buys Remdesivir to Treat 30,000 COVID Patients, Seeks More
|
Companies
Companies

Gilead’s $2,340 Price for Coronavirus Drug Draws Criticism

Gilead’s $2,340 Price for Coronavirus Drug Draws Criticism
|
US News
US News

NIH Trial: Gilead’s Drug Works Best in COVID Patients on Oxygen

NIH Trial: Gilead’s Drug Works Best in COVID Patients on Oxygen
|
Science
Science

Remdesivir Explained—What Makes This Drug Work Against Viruses?

Remdesivir Explained—What Makes This Drug Work Against Viruses?
|
PUBLIC HEALTH INFORMATION
PUBLIC HEALTH INFORMATION

3,000 Participants Added to Trials for Experimental COVID-19 Treatment

3,000 Participants Added to Trials for Experimental COVID-19 Treatment
|
AMERICA
AMERICA

CCP Virus Patients Rush to Join Studies of Gilead Drug

CCP Virus Patients Rush to Join Studies of Gilead Drug
|
Health
Health

How Much of Our Tax Money Goes to Big Pharma? A Lot.

How Much of Our Tax Money Goes to Big Pharma? A Lot.
|
Health
Health

Drug Maker Was Focused on Profits, Not Patients: Report

Drug Maker Was Focused on Profits, Not Patients: Report
|